Roli i antioxidantëve në menazhimin e faktorëve proatherogjen dhe protrombotik

Autorët

  • Patricia Daliu
  • Giuseppe Annunziata
  • Fabrizia Guerra

Abstrakti

Sëmundja e arterieve koronare që njihet ndryshe edhe si sëmundje ishemike e zemrës është shkaktari kryesor i vdekjeve në ditët e sotëshme në vendet e zhvilluara. Qëllimi i këtij studimi është që të ofrojë udhëzime parandaluese bazuara në evidencat e fundit mbi rëndësinë e antioksidantëve natyrore tek pacientët me patologji koronare përmes monitorimit të vlerave të trimetilaminëoxidazës (TMAO), metabolitit pro-atherogjen e protrombotik, të Low density lipoprotein (LDL-së), Proteinës C-Reaktive (PCR-së) duke testuar in vivo efikasitetin e një nutraceutiku me bazë ekstraktet polifenolike të resveratrolit përgatitur nga bërsitë e rrushit (Vitis vinifera L.)

Fjalët kyçe:

patologji koronare, trimetilamineoxidave, resveratrol, produkte natyrale, antioksidant.

Shkarkimet

Download data is not yet available.

References

  1. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Heart disease and stroke statistics’2017 update: a report from the American Heart Association. Circulation. (2017) 135:e146–603. doi: 10.1161/CIR.0000000000000485

  2. Zhu Y, Li Q, Jiang H. Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide. APMIS. (2020) 128:353–66. doi: 10.1111/apm.13038

  3. Shi X, He J, Lin M, Liu C, Yan B, Song H, et al. Comparative effectiveness of team-based care with a clinical decision support system versus team-based care alone on cardiovascular risk reduction among patients with diabetes: Rationale and design of the D4C trial. Am Heart

  4. J. (2021) 238:45–58. doi: 10.1016/j.ahj.2021.04.009

  5. Kaze AD, Santhanam P, Musani SK, Ahima R, Echouffo-Tcheugui JB. Metabolic dyslipidemia and cardiovascular outcomes in type 2 diabetes mellitus: findings from the look AHEAD study. J Am Heart Assoc. (2021) 10:e016947. doi: 10.1161/JAHA.120.016947

  6. Rostomian AH, Tang MC, Soverow J, Sanchez DR. Heterogeneity of treatment effect in SPRINT by age and baseline comorbidities: The greatest impact of intensive blood pressure treatment is observed among younger patients without CKD or CVD and in older patients with CKD or

  7. CVD. J Clin Hypertens (Greenwich). (2020) 22:1723–6. doi: 10.1111/jch.13955

  8. Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. (2013) 368:1575–84. doi:10.1056/NEJMoa1109400

  9. Zhang Y, Wang Y, Ke B and Du J (2021) TMAO: how gut microbiota contributes to heart failure. Transl Res 228, 109–125

  10. Annunziata G, Maisto M, Schisano C, Ciampaglia R, Narciso V, Hassan STS, et al. Effect of grape pomace polyphenols with or without pectin on TMAO serum levels assessed by LC/MS-based assay: a preliminary clinical study on overweight/obese subjects. Front Pharmacol.

  11. (2019) 10:575. doi: 10.3389/fphar.2019.00575

  12. Ivashkin V, Kashukh YA. Impact of L-carnitine and phosphatidylcholine containing products on the proatherogenic metabolite TMAO production and gut microbiome changes in patients with coronary artery disease. Vopr Pitan. (2019) 88:25–33. doi: 10.24411/0042-8833-2019-10038

  13. Pignatelli P, Menichelli D, Pastori D, Violi F. Oxidative stress and cardiovascular disease: new insights. Kardiol Pol. (2018) 76:713–722. doi: 10.5603/KP.a2018.007

Downloads

Botuar

2024-11-24

Si të citoni

Daliu, P., Annunziata, G., & Guerra, F. (2024). Roli i antioxidantëve në menazhimin e faktorëve proatherogjen dhe protrombotik. Optime, (1), 134–138. Retrieved from https://albanica.al/optime/article/view/5873

Numri

No. 1 (2024): Optime

Seksioni

Articles